НовостиBenzingaLUCID CAPITAL MARKETS Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $24 LUCID CAPITAL MARKETS Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $24 Benzinga 2026.09.24 11:38 (GMT+0) Открыть на Benzinga Другие новости